These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Pneumococcal and Meningococcal Vaccination among Michigan Children with Sickle Cell Disease. Wagner AL, Shrivastwa N, Potter RC, Lyon-Callo SK, Boulton ML. J Pediatr; 2018 May; 196():223-229. PubMed ID: 29555094 [Abstract] [Full Text] [Related]
25. Hepatitis B vaccination coverage among U.S. adolescents, National Immunization Survey-Teen, 2006. Jain N, Hennessey K. J Adolesc Health; 2009 Jun; 44(6):561-7. PubMed ID: 19465320 [Abstract] [Full Text] [Related]
26. Timing of adolescent meningococcal conjugate vaccination attitudes and practices of pediatricians and family medicine physicians. Allison MA, Cohn AC, Stokley S, Crane LA, O'Leary ST, Hurley LP, Babbel CI, Dong F, Gahm C, Temte JL, Kempe A. Am J Prev Med; 2011 Dec; 41(6):581-7. PubMed ID: 22099234 [Abstract] [Full Text] [Related]
27. ACOG Committee Opinion number 314, September 2005. Meningococcal vaccination for adolescents. American College of Obstetricians and Gynecologists. Obstet Gynecol; 2005 Sep; 106(3):667-9. PubMed ID: 16135612 [Abstract] [Full Text] [Related]
29. Using registry data to evaluate the 2004 pneumococcal conjugate vaccine shortage. Allred NJ, Stevenson JM, Kolasa M, Bartlett DL, Schieber R, Enger KS, Shefer A. Am J Prev Med; 2006 Apr; 30(4):347-50. PubMed ID: 16530623 [Abstract] [Full Text] [Related]
30. Preventing meningococcal infection in college students. Harrison LH. Clin Infect Dis; 2000 Apr; 30(4):648-51. PubMed ID: 10770724 [Abstract] [Full Text] [Related]
31. The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada. Bettinger JA, Scheifele DW, Le Saux N, Halperin SA, Vaudry W, Tsang R, Canadian Immunization Monitoring Program, Active (IMPACT). Pediatr Infect Dis J; 2009 Mar; 28(3):220-4. PubMed ID: 19209096 [Abstract] [Full Text] [Related]
32. Effectiveness of serogroup C meningococcal polysaccharide vaccine: results from a case-control study in Quebec. De Wals P, Deceuninck G, De Serres G, Boivin JF, Duval B, Remis R, Massé R. Clin Infect Dis; 2005 Apr 15; 40(8):1116-22. PubMed ID: 15791510 [Abstract] [Full Text] [Related]
33. Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain. Larrauri A, Cano R, García M, Mateo Sd. Vaccine; 2005 Jul 14; 23(32):4097-100. PubMed ID: 15908059 [Abstract] [Full Text] [Related]
34. Meningococcal vaccine: New product, new recommendations. Campos-Outcalt D. J Fam Pract; 2005 Apr 14; 54(4):324-6. PubMed ID: 15833222 [Abstract] [Full Text] [Related]
35. Meningococcal vaccine for infants? Campos-Outcalt D. J Fam Pract; 2012 Aug 14; 61(8):482-4. PubMed ID: 22871657 [Abstract] [Full Text] [Related]
36. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2012 Aug 31; 61(34):671-7. PubMed ID: 22932301 [Abstract] [Full Text] [Related]
38. Update on immunizations in children and adolescents. Ackerman LK. Am Fam Physician; 2008 Jun 01; 77(11):1561-8. PubMed ID: 18581836 [Abstract] [Full Text] [Related]
40. Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluation. De Wals P, Trottier P, Pépin J. Vaccine; 2006 Apr 24; 24(17):3500-4. PubMed ID: 16517032 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]